Gregory Lambrecht
Fundador en Intrinsic Therapeutics, Inc. .
Cargos activos de Gregory Lambrecht
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Intrinsic Therapeutics, Inc.
Intrinsic Therapeutics, Inc. Medical SpecialtiesHealth Technology Intrinsic Therapeutics, Inc. develops device-based therapies for soft-tissue injuries of the spine. It offers surgeons and patients better options for treating painful disc herniations that cause sciatica and low back pain. The company was founded by Gregory H. Lambrecht in 1999 and is headquartered in Woburn, MA. | Director/Miembro de la Junta | 01/01/1999 | - |
Fundador | 01/01/1999 | - | |
Coravin, Inc.
Coravin, Inc. Beverages: AlcoholicConsumer Non-Durables Coravin, Inc. develops new technology for tapping bottles of wine. Its system allows users to access and pour their favorite wines by the glass without pulling the cork. The firm offers wine access needles, triggers, capsules, clamps, needle assortment kits, carry cases, vintage needles, faster pour needles, standard replacement needles, wine bottle sleeve on bottles, and replacement base products. The company was founded by Greg Lambrecht and Josh Makower in 2011 and is headquartered in Burlington, MA. | Presidente | - | - |
Fundador | - | - |
Historial de carrera de Gregory Lambrecht
Antiguos cargos conocidos de Gregory Lambrecht.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Viacor, Inc.
Viacor, Inc. Medical SpecialtiesHealth Technology Viacor is a development stage company dedicated to pioneering catheter-based techniques for the treatment of heart valve disease contributing to congestive heart failure. Currently, they are focused on the development of a minimally invasive cardiac valve repair system to treat congestive heart failure (CHF) patients afflicted with mitral regurgitation (MR), or 'leaky' mitral valves - a common problem among patients with CHF. Over 750,000 patients in the United States alone have associated functional MR and their mortality rate is double that of patients without MR. Their goal is to provide a new therapeutic alternative that significantly expands the potential to treat this large heart failure population without the risks associated with current surgical procedures. Viacor's Percutaneous Transvenous Mitral Annuloplasty (PTMA®) device has the potential to offer effective treatment with minimal intervention. | Director/Miembro de la Junta | - | 04/04/2012 |
Fundador | 21/01/2010 | 04/04/2012 | |
PFIZER, INC. | Corporate Officer/Principal | - | - |
STRYKER CORPORATION | Ventas & Marketing | - | - |
Formación de Gregory Lambrecht.
Massachusetts Institute of Technology | Undergraduate Degree |
Estadísticas
Internacional
Estados Unidos | 7 |
Operativa
Founder | 3 |
Director/Board Member | 2 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 5 |
Finance | 2 |
Consumer Non-Durables | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
STRYKER CORPORATION | Health Technology |
PFIZER, INC. | Health Technology |
Empresas privadas | 3 |
---|---|
Intrinsic Therapeutics, Inc.
Intrinsic Therapeutics, Inc. Medical SpecialtiesHealth Technology Intrinsic Therapeutics, Inc. develops device-based therapies for soft-tissue injuries of the spine. It offers surgeons and patients better options for treating painful disc herniations that cause sciatica and low back pain. The company was founded by Gregory H. Lambrecht in 1999 and is headquartered in Woburn, MA. | Health Technology |
Viacor, Inc.
Viacor, Inc. Medical SpecialtiesHealth Technology Viacor is a development stage company dedicated to pioneering catheter-based techniques for the treatment of heart valve disease contributing to congestive heart failure. Currently, they are focused on the development of a minimally invasive cardiac valve repair system to treat congestive heart failure (CHF) patients afflicted with mitral regurgitation (MR), or 'leaky' mitral valves - a common problem among patients with CHF. Over 750,000 patients in the United States alone have associated functional MR and their mortality rate is double that of patients without MR. Their goal is to provide a new therapeutic alternative that significantly expands the potential to treat this large heart failure population without the risks associated with current surgical procedures. Viacor's Percutaneous Transvenous Mitral Annuloplasty (PTMA®) device has the potential to offer effective treatment with minimal intervention. | Health Technology |
Coravin, Inc.
Coravin, Inc. Beverages: AlcoholicConsumer Non-Durables Coravin, Inc. develops new technology for tapping bottles of wine. Its system allows users to access and pour their favorite wines by the glass without pulling the cork. The firm offers wine access needles, triggers, capsules, clamps, needle assortment kits, carry cases, vintage needles, faster pour needles, standard replacement needles, wine bottle sleeve on bottles, and replacement base products. The company was founded by Greg Lambrecht and Josh Makower in 2011 and is headquartered in Burlington, MA. | Consumer Non-Durables |
- Bolsa de valores
- Insiders
- Gregory Lambrecht
- Experiencia